STAT3 and hepatocellular carcinoma: STAT3 (p<0.001) and NOTCH1 (p<0.001) were again significantly activated in the HIR subgroup (Figure S6), strongly supporting the idea that these transcription factors and the signaling pathways associated with them play key roles in late de novo recurrence of HCC.